Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Jun. 28, 2014	Jun. 29, 2013
Operating activities:
Net income	$ 1,934,864	$ 3,820,330
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	967,081	954,345
Provision for losses on accounts receivable	127,980	49,784
Gain on sale and disposal of property and equipment		(916)
Increase in cash value of life insurance	(167,144)	(126,051)
Deferred compensation	(57,587)	(44,879)
Stock compensation expense	19,978	27,582
Changes in operating assets and liabilities:
Accounts receivable	1,757,013	(2,029,044)
Inventories	(293,514)	2,716,959
Prepaid expenses and other assets	(180,299)	(452,764)
Accounts payable and accrued expenses	(1,043,177)	517,142
Net cash provided by operating activities	3,065,195	5,432,488
Investing activities:
Purchases of property and equipment	(528,713)	(427,654)
Proceeds from sale of property and equipment		7,850
Payments for other assets	(68,494)	(87,376)
Net cash used for investing activities	(597,207)	(507,180)
Financing activities:
Dividends paid	(1,238,710)	(4,026,044)
Common stock issued upon exercise of options	273,397	147,665
Net cash used for financing activities	(965,313)	(3,878,379)
Effect of exchange rates on cash	(38,228)	(114,164)
Increase in cash and cash equivalents	1,464,447	932,765
Cash and cash equivalents at beginning of period	5,424,521	2,665,302
Cash and cash equivalents at end of period	$ 6,888,968	$ 3,598,067